BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28414818)

  • 1. TGFβ/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells.
    Bailey KL; Agarwal E; Chowdhury S; Luo J; Brattain MG; Black JD; Wang J
    PLoS One; 2017; 12(4):e0176096. PubMed ID: 28414818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFβ and IGF1R signaling activates protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells.
    Leiphrakpam PD; Brattain MG; Black JD; Wang J
    J Biol Chem; 2018 May; 293(21):8242-8254. PubMed ID: 29599290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells.
    Simms NA; Rajput A; Sharratt EA; Ongchin M; Teggart CA; Wang J; Brattain MG
    BMC Cancer; 2012 Jun; 12():221. PubMed ID: 22672900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between Hippo and TGFβ: Subcellular Localization of YAP/TAZ/Smad Complexes.
    Grannas K; Arngården L; Lönn P; Mazurkiewicz M; Blokzijl A; Zieba A; Söderberg O
    J Mol Biol; 2015 Oct; 427(21):3407-15. PubMed ID: 25937570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between transforming growth factor-β and Nur77 in dual regulations of inhibitor of differentiation 1 for colonic tumorigenesis.
    Niu B; Liu J; Lv B; Lin J; Li X; Wu C; Jiang X; Zeng Z; Zhang XK; Zhou H
    Nat Commun; 2021 May; 12(1):2809. PubMed ID: 33990575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDK4 inhibition and doxorubicin mediate breast cancer cell apoptosis through Smad3 and survivin.
    Tarasewicz E; Hamdan R; Straehla J; Hardy A; Nunez O; Zelivianski S; Dokic D; Jeruss JS
    Cancer Biol Ther; 2014 Oct; 15(10):1301-11. PubMed ID: 25006666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.
    Oerlecke I; Bauer E; Dittmer A; Leyh B; Dittmer J
    PLoS One; 2013; 8(1):e54261. PubMed ID: 23349840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-linked inhibitor of apoptosis protein (XIAP) regulation of cyclin D1 protein expression and cancer cell anchorage-independent growth via its E3 ligase-mediated protein phosphatase 2A/c-Jun axis.
    Cao Z; Zhang R; Li J; Huang H; Zhang D; Zhang J; Gao J; Chen J; Huang C
    J Biol Chem; 2013 Jul; 288(28):20238-47. PubMed ID: 23720779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WITHDRAWN: Restoration of transforming growth factor-beta receptor II expression in colon cancer cells with microsatellite instability increases metastatic potential in vivo.
    Liu XQ; Rajput A; Geng L; Ongchin M; Chaudhuri A; Wang J
    J Biol Chem; 2011 May; 286(18):16082-90. PubMed ID: 21454688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
    Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
    Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
    Wang J; Yang L; Yang J; Kuropatwinski K; Wang W; Liu XQ; Hauser J; Brattain MG
    Cancer Res; 2008 May; 68(9):3152-60. PubMed ID: 18451140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-487b-3p/GRM3/TGFβ signaling axis is an important regulator of colon cancer tumorigenesis.
    Yi H; Geng L; Black A; Talmon G; Berim L; Wang J
    Oncogene; 2017 Jun; 36(24):3477-3489. PubMed ID: 28114282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor γ (PPARγ) plays a critical role in the development of TGFβ resistance of H460 cell.
    Lin LC; Hsu SL; Wu CL; Liu WC; Hsueh CM
    Cell Signal; 2011 Oct; 23(10):1640-50. PubMed ID: 21664967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling.
    Chen J; Mitra A; Li S; Song S; Nguyen BN; Chen JS; Shin JH; Gough NR; Lin P; Obias V; He AR; Yao Z; Malta TM; Noushmehr H; Latham PS; Su X; Rashid A; Mishra B; Wu RC; Mishra L
    Cancer Res; 2020 May; 80(9):1819-1832. PubMed ID: 32127355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1.
    Huang YS; Jie N; Zhang YX; Zou KJ; Weng Y
    Int J Mol Med; 2018 Mar; 41(3):1397-1408. PubMed ID: 29286138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT.
    Liu Y; Chen L; Ko TC; Fields AP; Thompson EA
    Oncogene; 2006 Jun; 25(25):3565-75. PubMed ID: 16462766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFbeta modulates PTEN expression independently of SMAD signaling for growth proliferation in colon cancer cells.
    Chow JY; Cabral JA; Chang J; Carethers JM
    Cancer Biol Ther; 2008 Oct; 7(10):1694-9. PubMed ID: 18769113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death.
    Augeri DJ; Langenfeld E; Castle M; Gilleran JA; Langenfeld J
    Mol Cancer; 2016 Apr; 15():27. PubMed ID: 27048361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDLIM5 inhibits STUB1-mediated degradation of SMAD3 and promotes the migration and invasion of lung cancer cells.
    Shi Y; Wang X; Xu Z; He Y; Guo C; He L; Huan C; Cai C; Huang J; Zhang J; Li Y; Zeng C; Zhang X; Wang L; Ke Y; Cheng H
    J Biol Chem; 2020 Oct; 295(40):13798-13811. PubMed ID: 32737199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.